Obesity is a substantial public health challenge across the globe. The use of resistant starch has been proposed as a probable management strategy for complications of obesity. We investigated the effects of resistant starch intake on lipid profiles, glucose metabolism, antioxidant status, lipid peroxidation marker, blood pressure, and anthropometric variables in subjects with overweight or obesity. In this 12-week, randomized, double-blind, placebo-controlled, 2 × 2 crossover trial, 21 Participants (mean age, 35 ± 7.0 years; body mass index, 32.4 ± 3.5 kg/m2) were given 13.5 g Hi-Maize 260 or placebo daily for 4 weeks, separated by a 4-week washout period. Changes in total antioxidant status (p = 0.04) and serum concentrations of insulin in 52.4% participants with insulin levels above 16 µIU/mL at the baseline (p = 0.04) were significantly different in the three phases. In addition, the mean of serum high-density lipoprotein cholesterol after the intervention was significantly higher than after baseline value (p = 0.04). We found no significant differences in serum concentrations of total cholesterol, triacylglycerol, low-density lipoprotein cholesterol, fasting blood sugar, insulin, homeostatic model assessment of insulin resistance, quantitative insulin sensitivity check index, superoxide dismutase activity, malondialdehyde, blood pressure, and anthropometric variables in the three phases of baseline, after intervention with resistant starch and after placebo. Resistant starch consumption improved serum insulin concentrations, lipid profiles, and antioxidant status in subjects with overweight or obesity.
ClinicalTrials.gov Identifier:
Citations
Manganese (Mn) is an essential micronutrient for human and plays an important role as a cofactor for several enzymes involving fatty acid synthesis, hepatic gluconeogenesis, and oxidative stresses. Also, Mn intake status has been reported to have beneficial effects in reversing metabolic dysfunction including obesity and nonalcoholic steatosis which is linked to mitochondrial dysfunction and oxidative stresses, however, information on dietary Mn intake in Koreans are limited. Hence we investigated the relationship between dietary Mn intake and antioxidant defense factors in healthy and obese subjects. Total of 333 healthy subjects were recruited in the study and were assigned to one of three study groups: a normal group (18.5-22.9), a overweight group (23-24.9), and a obesity group (>25) according to their body mass index (BMI). We assessed Mn intakes (24-hr recall method) and several indicators for antioxidative defenses such as glutathione (GSH), glutathione peroxidase (GPx) and urinary malonaldehyde (MDA). Results showed that body weight and blood pressure of study subjects were increased in dependent of their BMI (p < 0.01). However dietary Mn intakes and oxidative stress biomarkers (GSH, GPx, and MDA) were not significantly different by groups defined by BMI. In correlation analysis adjusting for age, sex and energy intake, dietary Mn intake of the subjects in different BMI categories were not significantly correlated with GSH, GPx, MDA and showed a weak or no association with these oxidative stress markers. In conclusion dietary Mn intake at least in this study has a little or no influence on markers of oxidative status in both healthy and obese subjects.
Citations
First
Prev
